Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aiming for quality as well as quantity.

D B Jack1

  • 1MWEC, Glasgow, UK. 100344.1432@compuserve.com

Drug News & Perspectives
|December 24, 2004
PubMed
Summary
This summary is machine-generated.

Highly active antiretroviral therapy (HAART) is standard for HIV treatment, but new approaches like hydroxyurea and patient genotyping are being explored. Research also focuses on immune stimulation and developing an effective HIV vaccine, particularly for global strains.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outbreak of interior poliomyelitis in H. M. S. Jamaica.

Journal of the Royal Naval Medical Service·2010
Same author

Structures of D2 layers on LiF(001).

Journal of colloid and interface science·2010
Same author

Monte Carlo simulations of the adsorption of CO2 on the MgO(100) surface.

The Journal of chemical physics·2006
Same author

Novel medicines from nature.

Drug news & perspectives·2004
Same author

The search for new antifungal drugs and strategies continues.

Drug news & perspectives·2004
Same author

One hundred years of aspirin.

Lancet (London, England)·1997
Same journal

New drug discovery and development in India.

Drug news & perspectives·2013
Same journal

Are we living in the end of the blockbuster drug era?

Drug news & perspectives·2010
Same journal

Molecule of the Month. TAK-875.

Drug news & perspectives·2010
Same journal

Epigenetic alterations of tumor marker microRNAs: towards new cancer therapies.

Drug news & perspectives·2010
Same journal

Electroporation: a promising method for the nonviral delivery of DNA vaccines in humans?

Drug news & perspectives·2010
Same journal

Trioxaquines: hybrid molecules for the treatment of malaria.

Drug news & perspectives·2010
See all related articles

Area of Science:

  • Infectious Diseases
  • Virology
  • Pharmacology

Background:

  • Highly active antiretroviral therapy (HAART) is the current standard for HIV infection treatment.
  • Existing HAART regimens face challenges including patient compliance and drug resistance.
  • New therapeutic strategies and preventative measures are under investigation.

Purpose of the Study:

  • To review emerging therapeutic strategies and research directions in HIV treatment presented at the 4th International Congress on Drug Therapy in HIV Infection.
  • To highlight novel drug candidates, personalized medicine approaches, and vaccine development for HIV/AIDS.

Main Methods:

  • The content is based on presentations and discussions from the 4th International Congress on Drug Therapy in HIV Infection.
  • Key areas reviewed include advancements in antiretroviral therapy, potential new drugs, and adjunctive treatment strategies.

Related Experiment Videos

  • Discussions also covered patient-centered approaches and the development of an effective HIV vaccine.

    • Main Results:

    • Hydroxyurea is identified as a promising drug for future HIV treatment regimens.
    • Patient genotyping is emerging as a method for optimizing drug selection.
    • Research is exploring immune system stimulation and vaccine development to combat HIV/AIDS.

    Conclusions:

    • While HAART remains crucial, ongoing research into novel drugs like hydroxyurea and personalized approaches like genotyping is vital.
    • Stimulating the immune system and developing a broadly effective HIV vaccine are critical long-term goals.
    • Increased focus on HIV subtypes prevalent in developing nations is necessary for global impact.